Clinical Trials Logo

HIV clinical trials

View clinical trials related to HIV.

Filter by:

NCT ID: NCT05785169 Recruiting - Hiv Clinical Trials

Ending the HIV Epidemic With Equity: an Intervention to Reduce the Impact of Racism and Discrimination

TRAnscenDS
Start date: March 15, 2024
Phase: N/A
Study type: Interventional

The scope of this study is to engage Ryan White HIV/AIDS Program (RWHAP) funded organizations in the South/East US to co-develop context-responsive programs to reduce structural racism and discrimination (SRD) against Black, Indigenous, People of Color (BIPOC) living with HIV (PLH) and BIPOC healthcare workers. Six RWHAP clinics will be selected to participate and be assigned to one of three sequences (two clinics per cluster). All members will complete participate in interactive trainings to raise awareness of and reduce SRD, from the clinic policy level, to attitudes, to the clinic environment. All clinic members and select patients will complete self-administered surveys every 6 months over 18 months.

NCT ID: NCT05784714 Recruiting - HIV Clinical Trials

NOLA GEM: Feasibility and Acceptability of an mHealth Intervention for Violence-affected PLWH

Start date: July 14, 2023
Phase: N/A
Study type: Interventional

The objective of the proposed research is to conduct formative work to develop, pilot and refine a smartphone delivered intervention for violence affected people living with HIV utilizing a novel spatial-temporal methodology, geographical ecological momentary assessment (GEMA), to first identify the activity spaces and daily psychosocial experiences (mental health symptoms, substance use, self-efficacy, coping) impacting adherence and viral suppression, and apply them to intervention. Guided by an ecological perspective, the investigators will adapt Living in the Face of Trauma to a mobile platform with GEMA informed intervention targets. The resulting app shall be referred to as NOLA GEM. Our long-term goal is delivering accessible interventions informed by daily experiences that affect health for PLWH. The investigators will test feasibility, acceptability and preliminary efficacy of the GEMA-informed NOLA GEM app against GEMA alone on adherence and care, and secondary outcomes of mental health and substance use.

NCT ID: NCT05774548 Recruiting - Hiv Clinical Trials

LA PrEP Impact and Cost-effectiveness (TEAMS)

Start date: March 15, 2023
Phase: N/A
Study type: Interventional

This study will have three components: 1. Discrete choice experiments 2. Analysis of routine service data 3. Impact and cost-effectiveness analyses using results from 1 and 2

NCT ID: NCT05769270 Recruiting - Hiv Clinical Trials

Development of a Telehealth-delivered Peer Navigation and Coping Skills Intervention to Increase PrEP Use in Young Black MSM

Start date: April 1, 2022
Phase: N/A
Study type: Interventional

This proposal seeks to adapt an existing peer navigation protocol (by adding coping skills and using telehealth) to be feasible, acceptable, and capable of supporting both PrEP uptake and P-E adherence for YBMSM ages 15-24.

NCT ID: NCT05768763 Recruiting - HIV Clinical Trials

SEARCH SAPPHIRE Phase B

Start date: March 28, 2023
Phase: N/A
Study type: Interventional

This study will evaluate the effects of optimized dynamic prevention and treatment packages delivered in a precision community health model on HIV incidence, as well as other health outcomes, in a community randomized trial design.

NCT ID: NCT05752500 Recruiting - Hiv Clinical Trials

Optimization of a Behavioral Intervention to Increase Physical Activity in Older Adults Living With HIV

HiActivity
Start date: June 21, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to examine 3 interventions designed to increase physical activity in older adults with HIV. We will examine 3 potential components of an intervention package: physical activity coaching, cognitive behavioral therapy targeted toward common barriers to physical activity such as low motivation or chronic pain, and a Fitbit-based social support intervention. Our primary outcome will be physical activity, defined as steps per day. Results will guide choice of intervention components to be used in an optimized behavioral intervention.

NCT ID: NCT05746442 Recruiting - HIV Clinical Trials

Ending Tobacco Use Through Interactive Tailored Messaging for Cambodian People Living With HIV/AIDS

ProjectENDIT
Start date: January 11, 2023
Phase: N/A
Study type: Interventional

The goal of this research study is to test how well an automated text messaging smoking treatment program helps smokers with HIV quit smoking.

NCT ID: NCT05736588 Recruiting - HIV Clinical Trials

Elimisha HPV (Human Papillomavirus)

Start date: September 25, 2023
Phase: N/A
Study type: Interventional

This research study aims to develop a stigma-responsive educational intervention which includes simplified scripts that provide clear messages about HPV and video aimed at addressing fears and misperceptions from a peer perspective. These educational components will be incorporated into 'Elimisha' HPV a multi-level stigma-responsive cervical cancer prevention service delivery model.

NCT ID: NCT05729256 Recruiting - Hiv Clinical Trials

Alcohol and "Heat of the Moment" Sexual Decision Making

Start date: November 1, 2023
Phase: N/A
Study type: Interventional

HIV transmission remains a significant public health concern, especially among men who have sex with men (MSM). Condomless anal intercourse (CAI) continues to be the major route of transmission for MSM. Thus, to reduce the incidence of HIV, it is critical to identify how contextual risk factors influence CAI and develop behavioral strategies that modify risk factors directly or reduce their influence on behavior. This study will examine the mechanisms through which one of the central contextual risk factors, heavy drinking, influences sexual decision processes in the natural environment and test the benefit of a brief intervention designed to reduce sexual risk behavior among those who engage in heavy drinking.

NCT ID: NCT05719025 Recruiting - COVID-19 Clinical Trials

Markers of Neurological Damage Post Covid-19 in PLWH

NeuroCOV-HIV
Start date: October 24, 2022
Phase:
Study type: Observational [Patient Registry]

Both HIV infection and Covid-19 are associated to cognitive and psychiatric impairment, like anxiety and depression. These disturbs are well-known in HIV infection and partially characterized in Covid-19.